Cameron Kyle Gallaher, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 15630 N Preston Hwy, Bruceton Mills, WV 26525 Phone: 304-379-7000 |
Ms. Marcia S Beissell, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: Waterfront Market Suite 4, Bruceton Mills, WV 26525 Phone: 304-379-7000 Fax: 304-379-7000 |
Dr. Steven Christopher Lint, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 207 Morgantown St., Suite 2, Bruceton Mills, WV 26525 Phone: 304-379-7000 Fax: 304-379-7000 |
Emilie Jedamski, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 15630 N Preston Hwy, Bruceton Mills, WV 26525 Phone: 304-379-7000 |
Bruceton Wellness Center Pllc Chiropractor Medicare: Medicare Enrolled Practice Location: 207 Morgantown St. Suite 2, Bruceton Mills, WV 26525 Phone: 304-379-7000 Fax: 304-379-7010 |
News Archive
Results from two investigational Phase I trials of ZOLINZA (vorinostat) in combination with bortezomib provide preliminary anti-tumor activity in patients with relapsed and/or refractory multiple myeloma.
Doubt was cast on the legitimacy of using barter for health care services on April 21, when Republican Senate candidate Sue Lowden commented that in the "olden days" people paid doctors with "a chicken" or other goods. BizXchange, a barter exchange company with offices in Seattle, San Francisco and Dubai, has been offering its more than 2,000 members health care services via barter for the last eight years. Members have spent nearly $4 million on health care related services since BizX was founded in 2002.
The drugs of tomorrow may be discovered by computers. A proof-of-concept study published December 23 in Cell Systems demonstrates that with the right input of data about infectious yeast, a machine algorithm can learn to identify combinations of existing and previously unknown compounds that can work together as antifungal agents.
Researchers for Peregrine Pharmaceuticals presented today at the Strategic Research Institute's Clinical-Stage Product Partnering Summit in La Jolla, CA a summary of clinical experience with Tumor Necrosis Therapy (TNT). The TNT technology is being developed in the U.S. and Europe by Peregrine under the trade name Cotaraâ„¢. Over 200 patients have been treated with TNT world-wide and a TNT product has been approved to treat grade III or IV advanced lung cancer in the People's Republic of China. A Cotara registration study for brain cancer has been approved by the U.S. Food and Drug Administration, and a Phase I colorectal cancer study is on-going at Stanford University Medical Center.
Much about autism is unknown, but researchers from the University of Rochester Medical Center (URMC) are working to learn more about the neurodevelopmental disorder and its most effective treatments. A team of researchers from URMC joins researchers from across the world in San Diego this week for the 10th annual International Meeting for Autism Research (IMFAR).
› Verified 2 days ago